Showing results (31-40 of 414) with videos related to
Sort By:
Pageof 42
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 1, 1997
Non-corticosteroid anti-inflammatory drugs in asthma: clinical pharmacology and recommendations for useJ W de Jong, D S PostmaClinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 13, 2003
Bronchial responsiveness to adenosine-5'-monophosphate and methacholine as predictors for nasal symptoms due to newly introduced allergens. A follow-up study among laboratory animal workers and bakery apprenticesG de Meer, D S Postma, D HeederikThorax|September 1, 1995
Effects of propranolol inhalation on the diurnal increase in FEV1 and on propranolol airways responsiveness in atopic subjects with asthmaY Oosterhoff, G H Koëter, D S PostmaChest|October 1, 1993
Interstitial lung disease and myositis in a patient with simultaneously occurring sarcoidosis and sclerodermaH Groen, D S Postma, C G KallenbergClinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 17, 2001
The NK-2 receptor antagonist SR 48968C does not improve adenosine hyperresponsiveness and airway obstruction in allergic asthmaJ Kraan, H Vink-Klooster, D S PostmaChest|July 1, 1995
Adverse effects of eosinophilia and smoking on the natural history of newly diagnosed chronic bronchitisM D Lebowitz, D S Postma, B BurrowsChest|August 1, 1993
Plethysmographic parameters in the assessment of reversibility of airways obstruction in patients with clinical emphysemaF Gimeno, D S Postma, R van AltenaAnnals of Allergy|December 1, 1992
Comparison of three normal breathing techniques to assess reversibility of airway obstructionF Gimeno, D S Postma, R van AltenaThe European Respiratory Journal|December 22, 1999
The importance of genetic influences in asthmaH Los, G H Koppelman, D S PostmaPageof 42